Colorectal Cancer | Specialty

The OncLive Colorectal Cancer condition center page is a comprehensive resource for clinical news and expert insights on colorectal cancer treatment and management, with a focus on novel therapeutic strategies including checkpoint inhibitors and TKIs across lines of therapy. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in colorectal cancer.

Dr. Grothey on Treatment Landscape of mCRC

February 28th 2017

Axel Grothey, MD, medical oncologist, Mayo Clinic, discusses some of the therapeutic approaches in the field of metastatic colorectal cancer (CRC).

Ongoing Clinical Trials in Colorectal Cancer

February 10th 2017

Broad Molecular Profiling in Colorectal Cancer

February 10th 2017

Survivorship Care Plans in Colorectal Cancer

February 10th 2017

Colorectal Cancer: Dosing Strategies With Regorafenib

February 10th 2017

Trifluridine/Tipiracil in Advanced Colorectal Cancer

February 10th 2017

Setting Expectations in Third-Line Colorectal Cancer

February 10th 2017

Long-Term Therapeutic Strategies in Colorectal Cancer

February 10th 2017

Selective Internal Radiation Therapy in Colorectal Cancer

February 10th 2017

Intrahepatic Radiation in Colorectal Cancer

February 10th 2017

Management of Liver-Dominant Unresectable Colorectal Cancer

February 10th 2017

Neoadjuvant/Adjuvant Approaches in Colorectal Cancer

February 10th 2017

Curative Intent in Oligometastatic Colorectal Cancer

February 10th 2017

MSI Status and Immunotherapy in Advanced Colorectal Cancer

February 10th 2017

Antibody Selection and Right- Versus Left-Sided Colorectal Cancer

February 10th 2017

Understanding Tumor Sidedness in Colorectal Cancer

February 10th 2017

Dr. Loaiza-Bonilla on Trial of Left- and Right-Sided Colorectal Cancer

February 9th 2017

Arturo Loaiza-Bonilla, MD, medical oncologist, specializing in gastrointestinal malignancies, assistant professor of Clinical Medicine at the University of Pennsylvania, discusses a clinical trial focused on the differences between left- and right-sided tumors of colorectal cancer (CRC).

Expert Discusses PD-1 Success in MSI-H Colorectal Cancer

February 9th 2017

Michael J. Overman, MD, discusses the significance of the ongoing CheckMate-142 study and the next steps in microsatellite instability-high metastatic colorectal cancer.

Atezolizumab/Bevacizumab Combo Attains 90% DCR in MSI-High mCRC

February 7th 2017

Patients with microsatellite-high metastatic colorectal cancer responded to an immunotherapy-containing regimen, according to results of a preliminary clinical evaluation presented at the 2017 Gastrointestinal Cancers Symposium.

Napabucasin Linked With Objective Responses in Advanced CRC

February 7th 2017

As many as one-third of patients with treatment-resistant colorectal cancer attained objective responses with the stemness inhibitor napabucasin plus FOLFIRI chemotherapy with or without bevacizumab, according to evaluable results of a study presented at the 2017 Gastrointestinal Cancers Symposium.